欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Tyruko	Human	natalizumab	natalizumab	EMEA/H/C/005752	Sandoz GmbH	2023/09/22	Authorised
Tepkinly	Human	epcoritamab	epcoritamab	EMEA/H/C/005985	AbbVie Deutschland GmbH & Co. KG	2023/09/22	Authorised
Orserdu	Human	elacestrant	elacestrant	EMEA/H/C/005898	Stemline Therapeutics B.V.	2023/09/15	Authorised
Yesafili	Human	aflibercept	aflibercept	EMEA/H/C/006022	Biosimilar Collaborations Ireland Limited	2023/09/15	Authorised
Enrylaze	Human	crisantaspase	crisantaspase	EMEA/H/C/005917	Jazz Pharmaceuticals Ireland Limited	2023/09/15	Authorised
Tevimbra	Human	tislelizumab	tislelizumab	EMEA/H/C/005919	Beone Medicines Ireland Limited	2023/09/15	Authorised
Lyfnua	Human	gefapixant	gefapixant	EMEA/H/C/005476	Merck Sharp & Dohme B.V.	2023/09/15	Authorised
Tyenne	Human	tocilizumab	tocilizumab	EMEA/H/C/005781	Fresenius Kabi Deutschland GmbH	2023/09/15	Authorised
Inaqovi	Human	cedazuridine;decitabine	cedazuridine;decitabine	EMEA/H/C/005823	Otsuka Pharmaceutical Netherlands B.V.	2023/09/15	Authorised
Litfulo	Human	ritlecitinib	ritlecitinib tosilate	EMEA/H/C/006025	Pfizer Europe MA EEIG	2023/09/15	Authorised
Apretude	Human	cabotegravir	cabotegravir	EMEA/H/C/005756	ViiV Healthcare B.V.	2023/09/15	Authorised
Abrysvo	Human	respiratory syncytial virus vaccine (bivalent, recombinant)	respiratory syncytial virus vaccine (bivalent, recombinant)	EMEA/H/C/006027	Pfizer Europe MA EEIG	2023/08/23	Authorised
Talvey	Human	talquetamab	talquetamab	EMEA/H/C/005864	Janssen-Cilag International N.V.	2023/08/21	Authorised
Aquipta	Human	atogepant	atogepant	EMEA/H/C/005871	AbbVie Deutschland GmbH & Co. KG	2023/08/11	Authorised
Ztalmy	Human	ganaxolone	ganaxolone	EMEA/H/C/005825	Marinus Pharmaceuticals Emerald Limited	2023/07/26	Authorised
Columvi	Human	glofitamab	Glofitamab	EMEA/H/C/005751	Roche Registration GmbH	2023/07/07	Authorised
Lytgobi	Human	futibatinib	Futibatinib	EMEA/H/C/005627	Taiho Pharma Netherlands B.V.	2023/07/04	Authorised
Camzyos	Human	mavacamten	Mavacamten	EMEA/H/C/005457	Bristol-Myers Squibb Pharma EEIG	2023/06/26	Authorised
Opfolda	Human	miglustat	miglustat	EMEA/H/C/005695	Amicus Therapeutics Europe Limited	2023/06/26	Authorised
Sugammadex Piramal	Human	sugammadex	sugammadex sodium	EMEA/H/C/006083	Piramal Critical Care B.V.	2023/06/23	Authorised

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-